The promise of precision: exploring the role of remimazolam in paediatric anaesthesia.
Where this comes from
- Record sourced from PubMed, PMID 40355167.
- Also identified by DOI 10.1016/j.bja.2025.03.010 and PMC identifier 12106872.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Remimazolam represents a breakthrough in paediatric anaesthesia, with predictable pharmacokinetics and safety profile. A recent study provides key dosing data for children while noting the need for comparative trials, pharmacogenetic studies, and long-term safety evaluations. We highlight its potential for broad clinical use, but call for further research to optimise its integration into paediatric anaesthesia practice.
Medical subject headings
- Benzodiazepines
- Anesthesia
- Hypnotics and Sedatives
- Pediatrics
- Precision Medicine